Top Markets
#1 Islamic Coin Islamic Coin +155.97%
#2 Siren Siren +37.56%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.25%
#4 Verus Coin Verus Coin +22.40%
#5 Cysic Cysic +19.84%
#6 Arowana Arowana +19.40%
#7 OpenEden OpenEden +17.23%
#8 Perle Perle +14.78%
#9 Ocean Protocol Ocean Protocol +13.13%
#10 RedStone RedStone +12.61%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Endymed Ltd Endymed Ltd

Endymed Ltd

ENDY
Rank in Stocks #31811
Endymed Ltd is a medical technology company focused on the global design,... Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Share Price
$0.90225185
Last synced: 2025-02-16
Market Cap
$11.99M
Change (1 day)
0.48%
Change (1 year)
0.00%
Country
US
Trade Endymed Ltd (ENDY)

Category

Healthcare
Revenue for Endymed Ltd (ENDY)
Revenue in Sep 2024 TTM: $18.94M
According to Endymed Ltd latest financial reports the company's current revenue (TTM) is $18.94M. In 2022 the company made a revenue of $21.33M a decrease compared to the revenue in the year 2021 that was $21.78M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Endymed Ltd from 2013 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $18.94M -16.84%
2023 $22.78M 6.77%
2022 $21.33M -2.06%
2021 $21.78M 51.85%
2020 $14.35M -12.78%
2019 $16.45M -10.88%
2018 $18.45M 5.20%
2017 $17.54M 23.08%
2016 $14.25M 10.05%
2015 $12.95M 22.80%
2014 $10.55M 79.94%
2013 $5.86M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 245,821.98%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 136,293.39%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 187,219.85%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 110,737.78%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 34,278.40%
US